Developer docs
API playgroundTry for free, no card

Search company profiles

Alverno Laboratories

Full company profile

uuid000jcue

Namestring
Alverno Laboratories
Legal namestring
Alverno Laboratories, LLC
Websiteurl
alvernolabs.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Alverno Laboratories is a regional clinical laboratory network and joint venture between Franciscan Alliance and Ascension Illinois, founded in 1999 and headquartered in Hammond, Indiana. The company operates 32 hospital laboratories and nearly 40 total sites across Illinois and Indiana, performing 6,092,166 laboratory tests in 2024 and serving hospital systems, physician offices, freestanding emergency departments, clinical trial sponsors, and individual patients. Core services span anatomic pathology, molecular diagnostics, microbiology, toxicology, and general laboratory testing, supported by a technology stack that includes Philips IntelliSite digital pathology, Ibex Galen AI-assisted cancer diagnostics for prostate, breast, and gastric biopsies, Copan WASP full microbiology automation, Bruker Maldi-TOF mass spectrometry, Abbott real-time PCR systems, comprehensive NGS panels covering 500+ genes, and an 84-analyte urine drug confirmation panel.

The company's technology differentiators include being the first US laboratory to implement full microbiology automation and one of the first to routinely report clinical microbiology identifications via Maldi-TOF, the first US site to install Philips digital pathology services, and the first Midwest laboratory to deploy Ibex AI cancer diagnostics, with reported AUCs of 0.990 for breast and 0.991 for prostate cancer detection and 25-32% reductions in major diagnostic discrepancy rates. ISO 15189 certification, HIPAA and 21 CFR Part 2 compliance, and the proprietary Alverno Business Systems (ABS) quality framework underpin the operational model.

Alverno generates revenue through four primary streams: transaction-based clinical laboratory testing billed to insurance, Medicare/Medicaid, and self-pay patients; managed-service fees across a three-tier partnership model (Reference Testing Partnership, Strategic Hospital Cooperative, Integrated Network) for hospital partners; professional services for clinical trial sponsors; and direct-to-consumer testing via the MyAlvernoDirect platform. Distribution is anchored by shared EHR integration with Franciscan Health and Ascension Illinois, MedSpeed courier logistics, and a patient service center and drive-through collection network across the Midwest.

Short descriptiontext

Regional clinical laboratory joint venture between Franciscan Alliance and Ascension Illinois, operating 32 hospital laboratories and nearly 40 sites across Illinois and Indiana and performing over 6 million tests annually, with advanced diagnostics including AI-powered cancer detection and digital pathology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersHammond, United States
HQ citystring
Hammond
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices19 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, anatomic pathology diagnostics, microbiology testing, molecular diagnostics NGS, toxicology screening services
Industry5 codes
PRIMARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAFAMAD
Microbiology & Infectious Disease Testing Laboratories
SECONDARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
SECONDARYHLAGAEAF
Microbiology & Infectious Disease Testing (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Laboratory Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Clinical Laboratory Testing Services
TypeTransaction Fee
Description

Alverno Laboratories operates as a full-service clinical laboratory performing over 6 million laboratory tests annually for hospital systems, physician offices, ERs, and freestanding collection sites across Indiana and Illinois. Revenue is generated through billable laboratory testing services billed to insurance companies, third-party payors, Medicare/Medicaid, and self-pay patients.

alvernolabs.com
2Strategic Partnership Fees
TypeManaged Services
Description

Three-tiered partnership model (Level 1 Reference Testing Partnership, Level 2 Strategic Hospital Cooperative, Level 3 Integrated Network) generates revenue through laboratory management fees, testing consolidation savings sharing, and potential ownership interests for integrated network members.

alvernolabs.com
3Clinical Research and Trial Services
TypeProfessional Services
Description

Provides clinical trial laboratory services including project management, custom kit production, logistics with real-time tracking, pre-analytical services, and customized data management reports for sponsors conducting clinical research across Indiana and Illinois.

alvernolabs.com
4Direct-to-Consumer Lab Testing (MyAlvernoDirect)
TypeTransaction Fee
Description

Direct-to-consumer laboratory testing service allowing patients to self-order lab tests without a provider order, generating revenue from patients paying out-of-pocket or through insurance for ordered tests.

alvernolabs.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details1 tier
1Direct-to-consumer lab testing without provider order
ModelOtherBilling cadencePay-as-you-go
Notes

Patients can order laboratory tests directly through MyAlvernoDirect without a doctor's visit. Patients may pay out-of-pocket or bill insurance depending on coverage. Financial assistance is available.

alvernolabs.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Alverno Laboratories operates a full-service clinical reference laboratory network providing diagnostic testing across anatomic pathology, microbiology, molecular diagnostics, toxicology, and general laboratory disciplines. Services are delivered through 32 managed hospital laboratory sites plus a central laboratory in Hammond, Indiana, serving hospital systems, physician offices, and patients across Indiana and Illinois. The company also offers direct-to-consumer self-ordered testing through MyAlvernoDirect and clinical research trial support services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 6,092,166 laboratory tests performed in 2024
+7 more records
Product overview1 text field

Alverno Laboratories operates as a regional reference laboratory network with a central laboratory in Hammond, Indiana and 32 laboratory locations across Illinois and Indiana. The core product portfolio centers on diagnostic laboratory services spanning anatomic pathology (including digital pathology with Philips scanners and AI-assisted diagnosis via Ibex Galen), general laboratory testing, microbiology, molecular diagnostics, and toxicology. The company offers precision medicine testing including next-generation sequencing panels, and provides patients direct access through MyAlvernoDirect for self-ordered testing. Adjacent services include clinical research trial support and tiered partnership programs for hospitals. In 2024, the organization performed 6,092,166 laboratory tests.

Product and service11 records
1Anatomic Pathology Services
CategoryAnatomic Pathology
Description

Complete histology solutions including tissue sample processing, embedding, slide preparation with conventional and advanced staining methods, immunohistochemistry (IHC), and in situ hybridization (ISH) for hospital systems and referring physicians.

2Digital Pathology
CategoryAnatomic Pathology
Description

Philips IntelliSite Digital Image Management System with digital scanners for digitizing glass slides, enabling pathologists to review cases on computer screens with digital image tools for measurements and area marking.

3AI-Powered Cancer Diagnostics (Ibex Galen)
CategoryAnatomic Pathology
Description

AI-assisted cancer diagnosis platform deployed across 32 laboratory locations for prostate, breast, and gastric cancer detection, supporting pathologists with image analysis and yielding 25-32% reduction in major diagnostic discrepancy rates.

4General Laboratory Services
CategoryGeneral Laboratory
Description

Full-spectrum clinical chemistry, hematology, coagulation, serology, infectious disease diagnostics, urinalysis, allergy testing (ImmunoCAP), and blood bank operations for hospitals and physician offices.

5Microbiology Services
CategoryMicrobiology
Description

State-of-the-art Copan WASP automation for specimen processing, Bruker Maldi-TOF for rapid pathogen identification, BACTEC blood culture system, mycobacterium culture, fungal culture, and ova and parasite examination for hospital partners.

6Molecular Diagnostics
CategoryMolecular Diagnostics
Description

Next-generation sequencing (NGS) and real-time PCR for solid tumors, myeloid disorders, and infectious diseases. Includes precision medicine panels with 500+ genes, flow cytometry, FISH testing, and molecular microbiology.

7Toxicology Services
CategoryToxicology
Description

Mass spectrometry-based comprehensive toxicology testing including an 84-analyte urine drug confirmation panel covering commonly prescribed medications and drugs of abuse, immunosuppressant monitoring, vitamin D testing, and lead testing for pain management and behavioral health providers.

8Precision Medicine
CategoryPrecision Medicine
Description

Oncology testing with comprehensive solid tumor gene panel (500+ genes via NGS), myeloid panel, and partnership with Genomics Testing Cooperative (GTC) for advanced offerings including GTC-Solid Tumor Profile Plus (434 DNA, 1408 RNA genes), Hematology Profile Plus, and Liquid Trace liquid biopsy technology for oncology patients with complex cases.

9MyAlvernoDirect (Direct-to-Consumer Lab Testing)
CategoryDirect-to-Consumer Testing
Description

Patient-direct online ordering platform allowing individuals to select and order laboratory tests without a provider order, with specimen collection available at home or at Alverno Patient Service Centers, and payment via self-pay or insurance billing.

10Clinical Research and Trial Services
CategoryClinical Research Services
Description

Full-service clinical trial laboratory support including project management, custom kit production, logistics with real-time specimen tracking and temperature monitoring, pre-analytical services, and customized data management reports for pharmaceutical, biotech, and research sponsors across Indiana and Illinois.

11Hospital Partnership Programs
CategoryPartnership Services
Description

Three-tier structured partnership offering for hospital systems: Level 1 Reference Testing Partnership, Level 2 Strategic Hospital Cooperative, and Level 3 Integrated Network with potential ownership interest and Board membership, integrating Alverno's laboratory operations with partner hospital systems.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-05-05
Description

Ibex Medical Analytics partnered with Alverno Laboratories to deploy its AI-powered cancer diagnosis platform, Galen, across Alverno's 32 laboratories in the U.S. The platform aids pathologists in diagnosing breast and prostate cancers (and gastric biopsies in upcoming expansion), improving diagnostic accuracy. Alverno is the first laboratory in the Midwest and one of the first ten labs in the country to offer the Ibext platform. Implementation yields a 29% reduction in major discrepancy rate for breast cases and 32% for prostate cases.

Strategic tierCoreTypeTechnology or Integration
Description

Philips IntelliSite Digital Image Management System and digital scanners are deployed for digitizing pathology glass slides, enabling computer-based case review with digital image tools. Alverno was the first in the country to install Philips digital pathology services and is among the largest digital pathology providers globally.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership with Genomics Testing Cooperative provides access to GTC's advanced NGS offerings including Solid Tumor Profile Plus (434 DNA genes, 1408 RNA genes), Hematology Profile Plus (179 DNA genes, 1408 RNA genes), and Liquid Trace pan-cancer liquid biopsy technology (284 cfDNA genes, 1501 cfRNA). Enables oncology patients with complex cases to access advanced molecular diagnostics through Alverno.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

IPM serves as Alverno's proven project management partner to execute Level 2 and Level 3 partnership integrations, supporting seamless transitions and outstanding results for hospital laboratory integrations. IPM has extensive laboratory, hospital, and health system integration experience.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

MedSpeed provides courier service for Alverno's reference testing partnership (Level 1), picking up specimens from hospital partners and delivering them to Alverno's central laboratory in Hammond, Indiana.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Franciscan Health is a co-founder and key hospital system partner of Alverno Laboratories. The two organizations share an EHR system (electronic health record) for combined patient health records. Alverno manages laboratory operations at Franciscan Health hospital sites across Indiana (Munster, Dyer, Crown Point, Michigan City, Lafayette, Indianapolis, Mooresville, Olympia Fields, Rensselaer, Carmel, Crawfordsville, Chesterton, Woodland, Hammond). Alverno was originally formed through integration of Franciscan Alliance hospital laboratories.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ascension Illinois hospital system partners with Alverno Laboratories for laboratory management services at Ascension Illinois laboratory sites (Saint Joseph Hospital Chicago, Alexian Brothers Medical Center Elk Grove Village, Saint Alexius Medical Center Hoffman Estates). Alverno shares an EHR system with Ascension Illinois for combined patient health records.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Mount Sinai Hospital and Holy Cross Hospital in Chicago operate their laboratory operations under Alverno Laboratories management, integrating into the Alverno network of clinical laboratory services.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Largest US clinical reference laboratory network with national reach, full-service test menu, and direct payor contracts. Directly comparable as a full-service clinical/ esoteric reference lab competing for the same physician office send-out business, though at vastly greater geographic scale.

TypeRegional player
Description

Privately-held physician-led pathology and clinical lab serving hospitals and physicians across the Southeast US. Closely comparable to Alverno as a regional reference lab with deep anatomic pathology and molecular diagnostics focus, competing for similar hospital and outreach volume though in a different geography.

TypeOthers
Description

Indiana-based Catholic health system and co-founder/parent of Alverno Laboratories; Alverno manages all Franciscan hospital lab sites. Related party customer/owner that defines Alverno's anchor hospital volume and JV governance.

TypeRegional player
Description

Academic-based clinical laboratory and anatomic pathology group serving Northwestern Memorial and affiliated hospitals in the Chicagoland market. Overlaps directly with Alverno's Illinois/Indiana territory in the same geography and competes for esoteric send-outs from regional hospitals and physician offices.

TypeBroad incumbent
Description

Second major national reference lab offering routine and esoteric testing plus clinical trial central lab services through Labcorp Drug Development. Closest direct competitor for Alverno's clinical research trial business and physician send-out volume.

TypeDirect peer
Description

Reference laboratory arm of Mayo Clinic providing esoteric and routine testing globally with a strong hospital partnership model (MCHS@MCL). Directly comparable as a high-acuity reference lab with AI/digital pathology investments, oncology testing, and a similar tiered outreach offering to community hospitals.

TypeBroad incumbent
Description

Global reference lab operator with US presence including BioReference Laboratories; offers full clinical and esoteric testing with hospital partnerships. Comparable as a competing hospital-affiliated reference lab platform targeting IDN partnerships at scale.

TypeDirect peer
Description

Nonprofit academic reference laboratory affiliated with University of Utah operating as a regional/esoteric referral lab for hospitals across the western US. Same business model as Alverno (central reference lab serving hospital systems) with comparable esoteric testing portfolio, ISO accreditation, and hospital partnership structure.

TypeEmerging player
Description

Independent digital pathology and molecular diagnostics platform serving community hospitals and specialty practices. Comparable as a tech-forward pathology and oncology testing provider competing for the same hospital outreach and specialty referral volume that Alverno's anatomic pathology business targets.

TypeOthers
Description

Laboratory division of Ascension (one of Alverno's JV parents) operating across Ascension's footprint including Wisconsin and Michigan. Provides direct overlap with Alverno's hospital lab management operations and represents both a partner/affiliate relationship and a potential conflict-of-interest for JV economics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Alverno Laboratories

Clinical Laboratory Servicesalvernolabs.com

Regional clinical laboratory joint venture between Franciscan Alliance and Ascension Illinois, operating 32 hospital laboratories and nearly 40 sites across Illinois and Indiana and performing over 6 million tests annually, with advanced diagnostics including AI-powered cancer detection and digital pathology.

What Alverno Laboratories does

Alverno Laboratories is a regional clinical laboratory network and joint venture between Franciscan Alliance and Ascension Illinois, founded in 1999 and headquartered in Hammond, Indiana. The company operates 32 hospital laboratories and nearly 40 total sites across Illinois and Indiana, performing 6,092,166 laboratory tests in 2024 and serving hospital systems, physician offices, freestanding emergency departments, clinical trial sponsors, and individual patients. Core services span anatomic pathology, molecular diagnostics, microbiology, toxicology, and general laboratory testing, supported by a technology stack that includes Philips IntelliSite digital pathology, Ibex Galen AI-assisted cancer diagnostics for prostate, breast, and gastric biopsies, Copan WASP full microbiology automation, Bruker Maldi-TOF mass spectrometry, Abbott real-time PCR systems, comprehensive NGS panels covering 500+ genes, and an 84-analyte urine drug confirmation panel.

The company's technology differentiators include being the first US laboratory to implement full microbiology automation and one of the first to routinely report clinical microbiology identifications via Maldi-TOF, the first US site to install Philips digital pathology services, and the first Midwest laboratory to deploy Ibex AI cancer diagnostics, with reported AUCs of 0.990 for breast and 0.991 for prostate cancer detection and 25-32% reductions in major diagnostic discrepancy rates. ISO 15189 certification, HIPAA and 21 CFR Part 2 compliance, and the proprietary Alverno Business Systems (ABS) quality framework underpin the operational model.

Alverno generates revenue through four primary streams: transaction-based clinical laboratory testing billed to insurance, Medicare/Medicaid, and self-pay patients; managed-service fees across a three-tier partnership model (Reference Testing Partnership, Strategic Hospital Cooperative, Integrated Network) for hospital partners; professional services for clinical trial sponsors; and direct-to-consumer testing via the MyAlvernoDirect platform. Distribution is anchored by shared EHR integration with Franciscan Health and Ascension Illinois, MedSpeed courier logistics, and a patient service center and drive-through collection network across the Midwest.

Alverno Laboratories firmographics

Firmographics
Name
Alverno Laboratories
Legal name
Alverno Laboratories, LLC
Website
https://alvernolabs.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Regional clinical laboratory joint venture between Franciscan Alliance and Ascension Illinois, operating 32 hospital laboratories and nearly 40 sites across Illinois and Indiana and performing over 6 million tests annually, with advanced diagnostics including AI-powered cancer detection and digital pathology.
Ownership category
akta.pro rank

Alverno Laboratories industry classification

Industry
Product category
Clinical Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAFAMAL
Clinical Research & Trial Central Laboratories
SECONDARYHLAFAMAD
Microbiology & Infectious Disease Testing Laboratories
SECONDARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
SECONDARYHLAGAEAF
Microbiology & Infectious Disease Testing (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Clinical laboratory services
  • Anatomic pathology diagnostics
  • Microbiology testing
  • Molecular diagnostics NGS
  • Toxicology screening services

Where Alverno Laboratories is headquartered

Location

Headquarters

HQ city
Hammond
HQ country
United States
HQ region
North America

Offices19 records

Markets served

Alverno Laboratories business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Clinical Laboratory Testing Services: Alverno Laboratories operates as a full-service clinical laboratory performing over 6 million laboratory tests annually for hospital systems, physician offices, ERs, and freestanding collection sites across Indiana and Illinois. Revenue is generated through billable laboratory testing services billed to insurance companies, third-party payors, Medicare/Medicaid, and self-pay patients.
  2. Strategic Partnership Fees: Three-tiered partnership model (Level 1 Reference Testing Partnership, Level 2 Strategic Hospital Cooperative, Level 3 Integrated Network) generates revenue through laboratory management fees, testing consolidation savings sharing, and potential ownership interests for integrated network members.
  3. Clinical Research and Trial Services: Provides clinical trial laboratory services including project management, custom kit production, logistics with real-time tracking, pre-analytical services, and customized data management reports for sponsors conducting clinical research across Indiana and Illinois.
  4. Direct-to-Consumer Lab Testing (MyAlvernoDirect): Direct-to-consumer laboratory testing service allowing patients to self-order lab tests without a provider order, generating revenue from patients paying out-of-pocket or through insurance for ordered tests.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goDirect-to-consumer lab testing without provider order

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Alverno Laboratories product offering

Product offering

Core offering

Alverno Laboratories operates a full-service clinical reference laboratory network providing diagnostic testing across anatomic pathology, microbiology, molecular diagnostics, toxicology, and general laboratory disciplines. Services are delivered through 32 managed hospital laboratory sites plus a central laboratory in Hammond, Indiana, serving hospital systems, physician offices, and patients across Indiana and Illinois. The company also offers direct-to-consumer self-ordered testing through MyAlvernoDirect and clinical research trial support services.

Product overview

Alverno Laboratories operates as a regional reference laboratory network with a central laboratory in Hammond, Indiana and 32 laboratory locations across Illinois and Indiana. The core product portfolio centers on diagnostic laboratory services spanning anatomic pathology (including digital pathology with Philips scanners and AI-assisted diagnosis via Ibex Galen), general laboratory testing, microbiology, molecular diagnostics, and toxicology. The company offers precision medicine testing including next-generation sequencing panels, and provides patients direct access through MyAlvernoDirect for self-ordered testing. Adjacent services include clinical research trial support and tiered partnership programs for hospitals. In 2024, the organization performed 6,092,166 laboratory tests.

Differentiator

Problem solved

Functional benefit

Products and services

  • Anatomic Pathology Services Complete histology solutions including tissue sample processing, embedding, slide preparation with conventional and advanced staining methods, immunohistochemistry (IHC), and in situ hybridization (ISH) for hospital systems and referring physicians.
  • Digital Pathology Philips IntelliSite Digital Image Management System with digital scanners for digitizing glass slides, enabling pathologists to review cases on computer screens with digital image tools for measurements and area marking.
  • AI-Powered Cancer Diagnostics (Ibex Galen) AI-assisted cancer diagnosis platform deployed across 32 laboratory locations for prostate, breast, and gastric cancer detection, supporting pathologists with image analysis and yielding 25-32% reduction in major diagnostic discrepancy rates.
  • General Laboratory Services Full-spectrum clinical chemistry, hematology, coagulation, serology, infectious disease diagnostics, urinalysis, allergy testing (ImmunoCAP), and blood bank operations for hospitals and physician offices.
  • Microbiology Services State-of-the-art Copan WASP automation for specimen processing, Bruker Maldi-TOF for rapid pathogen identification, BACTEC blood culture system, mycobacterium culture, fungal culture, and ova and parasite examination for hospital partners.
  • Molecular Diagnostics Next-generation sequencing (NGS) and real-time PCR for solid tumors, myeloid disorders, and infectious diseases. Includes precision medicine panels with 500+ genes, flow cytometry, FISH testing, and molecular microbiology.
  • Toxicology Services Mass spectrometry-based comprehensive toxicology testing including an 84-analyte urine drug confirmation panel covering commonly prescribed medications and drugs of abuse, immunosuppressant monitoring, vitamin D testing, and lead testing for pain management and behavioral health providers.
  • Precision Medicine Oncology testing with comprehensive solid tumor gene panel (500+ genes via NGS), myeloid panel, and partnership with Genomics Testing Cooperative (GTC) for advanced offerings including GTC-Solid Tumor Profile Plus (434 DNA, 1408 RNA genes), Hematology Profile Plus, and Liquid Trace liquid biopsy technology for oncology patients with complex cases.
  • MyAlvernoDirect (Direct-to-Consumer Lab Testing) Patient-direct online ordering platform allowing individuals to select and order laboratory tests without a provider order, with specimen collection available at home or at Alverno Patient Service Centers, and payment via self-pay or insurance billing.
  • Clinical Research and Trial Services Full-service clinical trial laboratory support including project management, custom kit production, logistics with real-time specimen tracking and temperature monitoring, pre-analytical services, and customized data management reports for pharmaceutical, biotech, and research sponsors across Indiana and Illinois.
  • Hospital Partnership Programs Three-tier structured partnership offering for hospital systems: Level 1 Reference Testing Partnership, Level 2 Strategic Hospital Cooperative, and Level 3 Integrated Network with potential ownership interest and Board membership, integrating Alverno's laboratory operations with partner hospital systems.

Quantifiable outcome

  • 6,092,166 laboratory tests performed in 2024
  • +7 more outcomes

Companies that use Alverno Laboratories

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Alverno Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature7 records

Alverno Laboratories partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Ibex Medical AnalyticscoreTechnology or Integration · 5 May 2025Ibex Medical Analytics partnered with Alverno Laboratories to deploy its AI-powered cancer diagnosis platform, Galen, across Alverno's 32 laboratories in the U.S. The platform aids pathologists in diagnosing breast and prostate cancers (and gastric biopsies in upcoming expansion), improving diagnostic accuracy. Alverno is the first laboratory in the Midwest and one of the first ten labs in the country to offer the Ibext platform. Implementation yields a 29% reduction in major discrepancy rate for breast cases and 32% for prostate cases.
  • Philips (Philips IntelliSite Digital Pathology)coreTechnology or IntegrationPhilips IntelliSite Digital Image Management System and digital scanners are deployed for digitizing pathology glass slides, enabling computer-based case review with digital image tools. Alverno was the first in the country to install Philips digital pathology services and is among the largest digital pathology providers globally.
  • Genomics Testing Cooperative (GTC)coreTechnology or IntegrationPartnership with Genomics Testing Cooperative provides access to GTC's advanced NGS offerings including Solid Tumor Profile Plus (434 DNA genes, 1408 RNA genes), Hematology Profile Plus (179 DNA genes, 1408 RNA genes), and Liquid Trace pan-cancer liquid biopsy technology (284 cfDNA genes, 1501 cfRNA). Enables oncology patients with complex cases to access advanced molecular diagnostics through Alverno.
  • Integrated Project Management Company, Inc. (IPM)minorImplementation/ SI/ Consulting PartnerIPM serves as Alverno's proven project management partner to execute Level 2 and Level 3 partnership integrations, supporting seamless transitions and outstanding results for hospital laboratory integrations. IPM has extensive laboratory, hospital, and health system integration experience.
  • MedSpeedminorChannel Partner/ Reseller/ DistributorMedSpeed provides courier service for Alverno's reference testing partnership (Level 1), picking up specimens from hospital partners and delivering them to Alverno's central laboratory in Hammond, Indiana.
  • Franciscan HealthcoreStrategic or Co-development PartnerFranciscan Health is a co-founder and key hospital system partner of Alverno Laboratories. The two organizations share an EHR system (electronic health record) for combined patient health records. Alverno manages laboratory operations at Franciscan Health hospital sites across Indiana (Munster, Dyer, Crown Point, Michigan City, Lafayette, Indianapolis, Mooresville, Olympia Fields, Rensselaer, Carmel, Crawfordsville, Chesterton, Woodland, Hammond). Alverno was originally formed through integration of Franciscan Alliance hospital laboratories.
  • Ascension IllinoiscoreStrategic or Co-development PartnerAscension Illinois hospital system partners with Alverno Laboratories for laboratory management services at Ascension Illinois laboratory sites (Saint Joseph Hospital Chicago, Alexian Brothers Medical Center Elk Grove Village, Saint Alexius Medical Center Hoffman Estates). Alverno shares an EHR system with Ascension Illinois for combined patient health records.
  • Mount Sinai Hospital and Holy Cross Hospital (Chicago)minorStrategic or Co-development PartnerMount Sinai Hospital and Holy Cross Hospital in Chicago operate their laboratory operations under Alverno Laboratories management, integrating into the Alverno network of clinical laboratory services.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Alverno Laboratories competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: Largest US clinical reference laboratory network with national reach, full-service test menu, and direct payor contracts. Directly comparable as a full-service clinical/ esoteric reference lab competing for the same physician office send-out business, though at vastly greater geographic scale.
  • Laboratory Corporation of America (Labcorp): Second major national reference lab offering routine and esoteric testing plus clinical trial central lab services through Labcorp Drug Development. Closest direct competitor for Alverno's clinical research trial business and physician send-out volume.
  • Sonic Healthcare USA: Global reference lab operator with US presence including BioReference Laboratories; offers full clinical and esoteric testing with hospital partnerships. Comparable as a competing hospital-affiliated reference lab platform targeting IDN partnerships at scale.

Regional players

  • PathGroup: Privately-held physician-led pathology and clinical lab serving hospitals and physicians across the Southeast US. Closely comparable to Alverno as a regional reference lab with deep anatomic pathology and molecular diagnostics focus, competing for similar hospital and outreach volume though in a different geography.
  • Northwestern Medicine Pathology: Academic-based clinical laboratory and anatomic pathology group serving Northwestern Memorial and affiliated hospitals in the Chicagoland market. Overlaps directly with Alverno's Illinois/Indiana territory in the same geography and competes for esoteric send-outs from regional hospitals and physician offices.

Others

  • Franciscan Health: Indiana-based Catholic health system and co-founder/parent of Alverno Laboratories; Alverno manages all Franciscan hospital lab sites. Related party customer/owner that defines Alverno's anchor hospital volume and JV governance.
  • Ascension Laboratory Services (ACL Labs): Laboratory division of Ascension (one of Alverno's JV parents) operating across Ascension's footprint including Wisconsin and Michigan. Provides direct overlap with Alverno's hospital lab management operations and represents both a partner/affiliate relationship and a potential conflict-of-interest for JV economics.

Direct peers

  • Mayo Clinic Laboratories: Reference laboratory arm of Mayo Clinic providing esoteric and routine testing globally with a strong hospital partnership model (MCHS@MCL). Directly comparable as a high-acuity reference lab with AI/digital pathology investments, oncology testing, and a similar tiered outreach offering to community hospitals.
  • ARUP Laboratories: Nonprofit academic reference laboratory affiliated with University of Utah operating as a regional/esoteric referral lab for hospitals across the western US. Same business model as Alverno (central reference lab serving hospital systems) with comparable esoteric testing portfolio, ISO accreditation, and hospital partnership structure.

Emerging players

  • Strata Pathology Services: Independent digital pathology and molecular diagnostics platform serving community hospitals and specialty practices. Comparable as a tech-forward pathology and oncology testing provider competing for the same hospital outreach and specialty referral volume that Alverno's anatomic pathology business targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Alverno Laboratories social profiles

Digital presence

Alverno Laboratories compliance and trust

Trust signal

Compliance3 records

Alverno Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Alverno Laboratories leadership team

Management profile

Number of profiles

Profiles11 records

Alverno Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Alverno Laboratories M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alverno Laboratories

What does Alverno Laboratories do?

Alverno Laboratories operates a full-service clinical reference laboratory network providing diagnostic testing across anatomic pathology, microbiology, molecular diagnostics, toxicology, and general laboratory disciplines. Services are delivered through 32 managed hospital laboratory sites plus a central laboratory in Hammond, Indiana, serving hospital systems, physician offices, and patients across Indiana and Illinois. The company also offers direct-to-consumer self-ordered testing through MyAlvernoDirect and clinical research trial support services.

Is Alverno Laboratories a public or private company?

Alverno Laboratories is a private company. It is classified as corporate owned and is currently operating.

When was Alverno Laboratories founded?

Alverno Laboratories was founded in 1999. It employs 501 to 1,000 people.

Where is Alverno Laboratories based?

Alverno Laboratories is headquartered in Hammond, United States, in the North America region.

How does Alverno Laboratories make money?

Four revenue lines are on record. Clinical Laboratory Testing Services are the primary driver. The others are strategic Partnership Fees, clinical Research and Trial Services and direct-to-Consumer Lab Testing (MyAlvernoDirect).

Who are Alverno Laboratories's main competitors?

Broad incumbents on record are Quest Diagnostics, Laboratory Corporation of America (Labcorp) and Sonic Healthcare USA. Regional players are PathGroup and Northwestern Medicine Pathology. Others are Franciscan Health and Ascension Laboratory Services (ACL Labs). Direct peers are Mayo Clinic Laboratories and ARUP Laboratories. Strata Pathology Services is listed as an emerging player.

Does Alverno Laboratories have an API?

No public API is recorded for Alverno Laboratories.

What industry is Alverno Laboratories in?

Alverno Laboratories's product category is Clinical Laboratory Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories, with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AlvernolabsIbex Partners with Alverno Labs to Enhance U.S. Roll Out of AI Cancer Diagnosis PlatformIbex Medical Analytics has partnered with Alverno Laboratories to expand the use of its AI-powered cancer diagnosis platform, Galen, in the U.S. market. The partnership involves deploying the platform in Alverno's 32 laboratories to improve the diagnosis of breast and prostate cancers, with the aim of aiding pathologists and increasing diagnostic accuracy.DarkdailyAI in Clinical Laboratories Will Drive Business Forward for Diagnostic Leaders, Experts SayAt the 2025 Executive War College, experts discussed AI's role in clinical labs, with Alverno Laboratories CEO Sam Terese citing cost control and rapid adoption. He noted patient trust is low but AI could drive revenue, while others warned AI should be used as a copilot with error-tolerant systems.AlvernolabsAlverno LaboratoriesAlverno Laboratories announced modified hours for its patient service centers during the upcoming holiday, closing all locations on November 27th and 28th, and the Crown Point PSC and Old Town PSC in Chicago will also be closed on November 29th. The changes are aimed at accommodating the holiday schedule.https://www.wndu.comAI helping Michiana doctors recognize health concernsAlverno Laboratories partnered with Franciscan Health and other health systems to integrate AI into digital pathology, using heat maps to flag abnormal cells. The technology aims to speed diagnoses and prioritize challenging cases, with expansion planned for melanoma detection.GlobeNewswireALVERNO LABORATORIES LAUNCHES SECOND AI-POWERED CANCER DIAGNOSTICS PLATFORM POWERED BY IBEX MEDICAL ANALYTICSAlverno Laboratories launched the Ibex Breast AI cancer diagnostics platform in routine practice across its Illinois and Indiana labs. The launch is part of a phased rollout that now covers prostate and breast biopsies, with gastric coming soon. The platform aims to speed results and improve pathologist productivity.Ibex-AiAlverno laboratories launches into the era of AI-powered pathology with Ibex Medical AnalyticsAlverno Laboratories and Ibex Medical Analytics announced on June 18, 2024 that Ibex's AI platform is being deployed in routine practice across Alverno's laboratory network in Illinois and Indiana, covering prostate, breast and gastric cancer detection. Phase 1 enabled AI-powered prostate cancer detection, followed by breast and gastric. Alverno serves over 30 hospital laboratories and thousands of physician offices, touching more than 8 million patients annually.TmcnetAlverno Laboratories Launches Into the Era of AI-Powered Pathology With Ibex Medical AnalyticsAlverno Laboratories and Ibex Medical Analytics launched an AI-powered pathology platform in routine practice across Alverno's Illinois and Indiana labs. The phased rollout includes prostate, breast, and gastric cancer detection, with prostate already enabled. The system aims to improve diagnostic accuracy and turnaround times.YahooALVERNO LABORATORIES LAUNCHES INTO THE ERA OF AI-POWERED PATHOLOGY WITH IBEX MEDICAL ANALYTICSAlverno Laboratories launched Ibex Medical Analytics' AI platform for cancer diagnosis in routine practice across its Illinois and Indiana network. The phased launch covers prostate, breast, and gastric biopsies, with prostate detection completed first. The system serves over 30 hospital labs and thousands of physician offices.Business Wire BlogAlverno Laboratories Launches Into the Era of AI-Powered Pathology With Ibex Medical AnalyticsAlverno Laboratories launched Ibex Medical Analytics' AI platform in routine practice across its Illinois and Indiana network, covering prostate, breast, and gastric cancer diagnosis. The phased launch began with prostate cancer detection for biopsies, followed by breast and gastric. The system serves over 30 hospital laboratories and thousands of physician offices.PR NewswireIbex and Alverno Laboratories Sign Multi-Year, Multi-Tissue Expansion Agreement of AI for Cancer DiagnosisAlverno Laboratories and Ibex Medical Analytics announced a multi-year expansion agreement to deploy Ibex's AI-powered Galen suite of cancer diagnostic solutions across Alverno's entire laboratory network in Illinois and Indiana. The deployment covers multiple tissue types including breast, prostate, and gastric biopsies, making Alverno the first laboratory in the U.S. Midwest to offer AI-supported cancer diagnosis. The expanded partnership supports 31 hospital laboratories touching over 8 million patients annually, with the technology aimed at improving diagnostic accuracy, reducing turnaround times, and increasing pathologists' productivity.